Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1979-12-18
|
pubmed:abstractText |
Fifty-three uterine cancer patients who complained of the syndrome dur to vasomotor manifestations or psychosomatic response after ovariectomy were given Premarin tablets, 1.25 mg per day or placebo for 3 weeks and improvement in their complaints was compared from the psychosomatic aspects by the double-blind method. Premarin was significantly more effective than placebo (P less than 0.001) in the psychologically normal patients. On the other hand, no difference in the effectiveness of these drugs were found in the psychologically abnormal patients (P = 0.119). According to the self evaluation by the patients, Premarin was significantly more effective than placebo (P less than 0.05) in the psychologically normal patients. However, there was no difference in the effects of these agents in the psychologically abnormal patients.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0378-5122
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
113-9
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:226841-Adult,
pubmed-meshheading:226841-Castration,
pubmed-meshheading:226841-Double-Blind Method,
pubmed-meshheading:226841-Estrogens,
pubmed-meshheading:226841-Estrogens, Conjugated (USP),
pubmed-meshheading:226841-Female,
pubmed-meshheading:226841-Humans,
pubmed-meshheading:226841-Middle Aged,
pubmed-meshheading:226841-Personality Inventory,
pubmed-meshheading:226841-Psychiatric Status Rating Scales,
pubmed-meshheading:226841-Psychophysiologic Disorders,
pubmed-meshheading:226841-Syndrome,
pubmed-meshheading:226841-Uterine Neoplasms,
pubmed-meshheading:226841-Vasomotor System
|
pubmed:year |
1978
|
pubmed:articleTitle |
Psychosomatic aspects of the effect of conjugated estrogens in patients with postoperative ovarian deficiency syndrome.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Controlled Clinical Trial
|